by Eric Christianson | Apr 23, 2023 | Cardiovascular Case Studies, Infectious Disease and Oncology Case Studies
One thing I always encourage is critical thinking. Reviewing a diagnosis list will give you clues as to the likely medications that a patient is taking or should be taking if they are following guideline-based medication therapy. In this Bactrim CHF case study, I...
by Eric Christianson | Apr 19, 2023 | Cardiovascular Medication and Disease State Clinical Pearls, Drug Interaction Case Studies and Education For Pharmacists
Beta-blockers are a class of medication that is frequently used for cardiac and cardiovascular purposes. Selectivity and evidence of benefit often guide selection, but one thing that may get overlooked is beta-blocker interactions in relation to CYP enzymes. Not all...
by Eric Christianson | Apr 9, 2023 | Cardiovascular Medication and Disease State Clinical Pearls
Bempedoic acid, also known as Nexletol, is a once-daily medication used in patients with increased atherosclerotic cardiovascular disease (ASCVD) or heterozygous familial hypercholesterolemia who are requiring additional LDL-C lowering previously on a maximally...
by Eric Christianson | Mar 26, 2023 | Neurology, Pain, and Musculoskeletal Medication and Disease State Clinical Pearls
I don’t recall learning about oxycodone pharmacokinetics in school. Cut me some slack, maybe I was gone that day? Or maybe my memory is fading? It’s actually pretty complicated and drug interactions and pharmacogenomics can play a significant role in how a...
by Eric Christianson | Mar 19, 2023 | Endocrine Medication and Disease State Clinical Pearls
Tirzepatide is a newer medication that is likely to get significant use in Type 2 diabetes and weight management. With the help of a wonderful pharmacy student, we previously did a tirzepatide clinical breakdown which you can find here. Tirzepatide avoids many drug...
